Teva_TV56286-NDG-20039

Teva_TV56286-NDG-20039

by ERT,INC

1 ratings
Free

Rating summary
0
0
0
1
0

Details

Released
December 9, 2023
Updated
October 31, 2026

Features

Teva_TV56286-NDG-20039 screenshot #1 for iPhone
Teva_TV56286-NDG-20039 screenshot #2 for iPhone
Teva_TV56286-NDG-20039 screenshot #3 for iPhone
Teva_TV56286-NDG-20039 screenshot #4 for iPhone
Teva_TV56286-NDG-20039 screenshot #5 for iPhone
Teva_TV56286-NDG-20039 screenshot #6 for iPhone
Teva_TV56286-NDG-20039 screenshot #7 for iPhone
Teva_TV56286-NDG-20039 screenshot #8 for iPhone
Teva_TV56286-NDG-20039 screenshot #9 for iPhone
Teva_TV56286-NDG-20039 screenshot #10 for iPhone
iphone
ipad
🖼️Get Icon
Icons↘︎

About

This app is designed for patients participating in clinical trials to report outcomes. Users require an account provided by a clinical trial site to access and log their data.

✓Patient-reported outcome collection
✓Clinical trial data entry
✓Secure user login
✓Site-provided accounts required
Show original description

What's New in Teva_TV56286

2.15.6 (66)

October 31, 2026

Addition of optional Handheld Training Module

Developer apps

FAQ

What is Teva_TV56286-NDG-20039 used for?

Teva_TV56286-NDG-20039 is an eCOA (electronic clinical outcome assessment) app designed for patients to report outcomes related to a clinical trial. It allows for the collection of patient-reported data during research studies.

How do I get an account for Teva_TV56286-NDG-20039?

You cannot create an account for Teva_TV56286-NDG-20039 on your own. Patients must be given login credentials by a participating clinical trial site to access the app.

Is Teva_TV56286-NDG-20039 free to use?

Yes, Teva_TV56286-NDG-20039 is available for free. There are no costs associated with downloading or using the application itself.

What devices does Teva_TV56286-NDG-20039 support?

Teva_TV56286-NDG-20039 is supported on iPhone, iPad, and iPod devices. This ensures accessibility for a range of Apple mobile users.

What is the age rating for Teva_TV56286-NDG-20039?

The app has an age rating of 12+, making it suitable for users aged 12 and older. This rating is based on content and intended use.

How often is Teva_TV56286-NDG-20039 updated?

The latest version of Teva_TV56286-NDG-20039 is 2.15.5 (60), released on December 4, 2025. Updates are provided periodically to improve functionality and address any issues.

What is the user feedback on Teva_TV56286-NDG-20039?

Based on available data, Teva_TV56286-NDG-20039 has a rating of 2.0 stars from 1 rating. This indicates a low user satisfaction score from the limited feedback received.

Does Teva_TV56286-NDG-20039 have ads?

No, Teva_TV56286-NDG-20039 does not contain advertisements. The app is ad-free, ensuring an uninterrupted experience for patients reporting their outcomes.